189 related articles for article (PubMed ID: 37400573)
1. LncRNAs associated with vascular mimicry establish a novel molecular subtype and prognostic model for pancreatic cancer.
Li D; Zhang Q; Tang Y; Mao F; Zeng J; Ji A
J Cancer Res Clin Oncol; 2023 Oct; 149(13):11571-11584. PubMed ID: 37400573
[TBL] [Abstract][Full Text] [Related]
2. Comprehensive analysis of tumor immune microenvironment and prognosis of m6A-related lncRNAs in gastric cancer.
Wang Y; Zhu GQ; Tian D; Zhou CW; Li N; Feng Y; Zeng MS
BMC Cancer; 2022 Mar; 22(1):316. PubMed ID: 35331183
[TBL] [Abstract][Full Text] [Related]
3. Clinicopathological and Prognostic Value of Necroptosis-Associated lncRNA Model in Patients with Kidney Renal Clear Cell Carcinoma.
Gu J; He Z; Huang Y; Luan T; Chen Z; Wang J; Ding M
Dis Markers; 2022; 2022():5204831. PubMed ID: 35664432
[TBL] [Abstract][Full Text] [Related]
4. Analysis of N6-methyladenosine-related lncRNAs in the tumor immune microenvironment and their prognostic role in pancreatic cancer.
Liu Y; Wang T; Fang Z; Kong J; Liu J
J Cancer Res Clin Oncol; 2022 Jul; 148(7):1613-1626. PubMed ID: 35314871
[TBL] [Abstract][Full Text] [Related]
5. Identification of cuproptosis-related subtypes, construction of a prognosis model, and tumor microenvironment landscape in gastric cancer.
Wang J; Qin D; Tao Z; Wang B; Xie Y; Wang Y; Li B; Cao J; Qiao X; Zhong S; Hu X
Front Immunol; 2022; 13():1056932. PubMed ID: 36479114
[TBL] [Abstract][Full Text] [Related]
6. N6-Methyladenosine-Related LncRNAs Are Potential Remodeling Indicators in the Tumor Microenvironment and Prognostic Markers in Osteosarcoma.
Wu Z; Zhang X; Chen D; Li Z; Wu X; Wang J; Deng Y
Front Immunol; 2021; 12():806189. PubMed ID: 35095893
[TBL] [Abstract][Full Text] [Related]
7. Novel chemokine related LncRNA signature correlates with the prognosis, immune landscape, and therapeutic sensitivity of esophageal squamous cell cancer.
Zhang Z; Wang J; Han W; Zhao L
BMC Gastroenterol; 2023 Apr; 23(1):132. PubMed ID: 37081402
[TBL] [Abstract][Full Text] [Related]
8. Expression profiling of long noncoding RNAs associated with vasculogenic mimicry in osteosarcoma.
Ren K; Ni Y; Li X; Wang C; Chang Q; Li Y; Gao Z; Wu S; Shi X; Song J; Yao N; Zhou J
J Cell Biochem; 2019 Aug; 120(8):12473-12488. PubMed ID: 30825232
[TBL] [Abstract][Full Text] [Related]
9. Construction of a novel model based on cell-in-cell-related genes and validation of KRT7 as a biomarker for predicting survival and immune microenvironment in pancreatic cancer.
Song J; Ruze R; Chen Y; Xu R; Yin X; Wang C; Xu Q; Zhao Y
BMC Cancer; 2022 Aug; 22(1):894. PubMed ID: 35974300
[TBL] [Abstract][Full Text] [Related]
10. Angiogenesis-related lncRNAs predict the prognosis signature of stomach adenocarcinoma.
Han C; Zhang C; Wang H; Li K; Zhao L
BMC Cancer; 2021 Dec; 21(1):1312. PubMed ID: 34876056
[TBL] [Abstract][Full Text] [Related]
11. Cross-Talk Between m
Song W; Ren J; Xiang R; Yuan W; Fu T
Front Immunol; 2022; 13():740960. PubMed ID: 35350786
[TBL] [Abstract][Full Text] [Related]
12. Molecular subtyping based on TRP family and prognostic assessment for TRP-associated lncRNAs in pancreatic adenocarcinoma.
Li L; Xiao Z; He P; Zou W; Deng Z; Zhang G; Liu R
BMC Gastroenterol; 2022 Nov; 22(1):454. PubMed ID: 36371178
[TBL] [Abstract][Full Text] [Related]
13. Cuproptosis-Related LncRNA-Based Prediction of the Prognosis and Immunotherapy Response in Papillary Renal Cell Carcinoma.
Pang Y; Wang Y; Zhou X; Ni Z; Chen W; Liu Y; Du W
Int J Mol Sci; 2023 Jan; 24(2):. PubMed ID: 36674979
[TBL] [Abstract][Full Text] [Related]
14. System Analysis Based on Pancreatic Cancer Progression Identifies BRINP2 as a Novel Prognostic Biomarker.
Kang Y; Xu X; Liu J
Crit Rev Eukaryot Gene Expr; 2023; 33(7):1-16. PubMed ID: 37602449
[TBL] [Abstract][Full Text] [Related]
15. Identification of glycolysis-associated long non-coding RNA regulatory subtypes and construction of prognostic signatures by transcriptomics for bladder cancer.
Mao C; Gao Y; Wan M; Xu N
Funct Integr Genomics; 2022 Aug; 22(4):597-609. PubMed ID: 35420332
[TBL] [Abstract][Full Text] [Related]
16. M6A-related lncRNAs predict clinical outcome and regulate the tumor immune microenvironment in hepatocellular carcinoma.
Chen B; Yang Z; Lang Z; Tao Q; Zhang R; Zhan Y; Xu X; Zhu K; Zheng J; Yu Z; Yu S
BMC Cancer; 2022 Aug; 22(1):867. PubMed ID: 35941582
[TBL] [Abstract][Full Text] [Related]
17. Characterization of anoikis-based molecular heterogeneity in pancreatic cancer and pancreatic neuroendocrine tumor and its association with tumor immune microenvironment and metabolic remodeling.
Li N; Jia X; Wang Z; Wang K; Qu Z; Chi D; Sun Z; Jiang J; Cui Y; Wang C
Front Endocrinol (Lausanne); 2023; 14():1153909. PubMed ID: 37234801
[TBL] [Abstract][Full Text] [Related]
18. Identification of a RNA-Seq Based 8-Long Non-Coding RNA Signature Predicting Survival in Esophageal Cancer.
Fan Q; Liu B
Med Sci Monit; 2016 Dec; 22():5163-5172. PubMed ID: 28028307
[TBL] [Abstract][Full Text] [Related]
19. Identification and validation of tumor microenvironment-related lncRNA prognostic signature for uveal melanoma.
Liao CL; Hu N; Sun XY; Zhou Q; Tian M; Cao Y; Lyu HB
Int J Ophthalmol; 2021; 14(8):1151-1159. PubMed ID: 34414077
[TBL] [Abstract][Full Text] [Related]
20. Oncogenic signaling pathway-related long non-coding RNAs for predicting prognosis and immunotherapy response in breast cancer.
Li H; Liu H; Hao Q; Liu X; Yao Y; Cao M
Front Immunol; 2022; 13():891175. PubMed ID: 35990668
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]